SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-13-000206
Filing Date
2013-03-26
Accepted
2013-03-26 16:04:52
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2012 appy_10k-123112.htm 10-K 1288353
2 EXHIBIT 10.12 ex10x12.htm EX-10.12 6093
3 EXHIBIT 14 ex14.htm EX-14 37829
4 EXHIBIT 23.1 ex23x1.htm EX-23.1 3371
5 EXHIBIT 31.1 ex31x1.htm EX-31.1 15285
6 EXHIBIT 31.2 ex31x2.htm EX-31.2 14562
7 EXHIBIT 32 ex32.htm EX-32 8836
  Complete submission text file 0001079973-13-000206.txt   7358859

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE appy-20121231.xml EX-101.INS 1113079
9 XBRL SCHEMA FILE appy-20121231.xsd EX-101.SCH 50907
10 XBRL CALCULATION FILE appy-20121231_cal.xml EX-101.CAL 46703
11 XBRL DEFINITION FILE appy-20121231_def.xml EX-101.DEF 193614
12 XBRL LABEL FILE appy-20121231_lab.xml EX-101.LAB 639846
13 XBRL PRESENTATION FILE appy-20121231_pre.xml EX-101.PRE 323944
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33675 | Film No.: 13716920
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1